(Received for publication August 21, 1996) Semi-synthetic modification of the cephalosporin nucleus has provided several generations of innovative, and clinically significant anti-infective agents.1} Of particular interest, the introduction of a direct C-3 olefinic linkage led to the discovery of cefixime and cefdinir, potent orally absorbed agents that enjoy widespread clinical application.2~4)
As part of the study of structure activity relationships of C-3 carbon linked substituents, we earlier reported the synthesis and biological evaluation of several 3-ethynylcephalosporins.5 '6) In particular, carboxymethoxyimino derivative 7b, the alkyne analog of cefixime, was characterized by good antibacterial activity against both Gram-negative and Gram-positive bacteria and was orally absorbed.5) In contrast, hydroxyimino derivative 7a, the alkyne analog of cefdinir, had reduced antibacterial activity and very low oral absorption.6) In a continuation of research into the synthesis of novel C-3 carbon linked derivatives, we wish to disclose the synthesis and antibacterial evaluation of novel substituted alkynes, including several bearing hydrophilic substituents, that had improved antibacterial activity in comparison to the previously reported alkynes 7a and7b.
Our strategy for the synthesis of the novel alkynes prepared in this work is outlined in Scheme 1. Whilst we reported earlier5) that alkyne 3b could be obtained smoothly from the corresponding cephalosporin-3-formyl derivatives by application of the well known Corey-Fuchs alkynation process via 2,2-dibromoolefins, attempts to derive higher analogs by anion generation and alkylation of 3b were unsuccessful. However, ap- (conveniently obtained from the corresponding alkynes (s, 3H)]. The lower yields in these reactions were neverby lithiation and quench with tributyltin chloride, as theless acceptable since the more commonlyemployed outlined in Scheme 2) with the mesylate derivative 1 triflates were somewhat unstable in our hands. In sharp proceeded in low to moderate yield to provide acetylenes contrast 1 is exceptionally stable and can be stored for 3a, 3c, 3e and 3f. For example, treatment of 1 in DMF prolonged periods. Whilst we did not establish the (-0.5mmol/ml solution) at 0°C with LiBr (2equiv.), identity of reaction by-products in all cases, the A1 bis(acetonitrile)palladium(II)chloride (5 mol%) and isomer of 1 was a major by-product in several cases and stannane 2c (1.1 equiv.) for 1 hour at 0°C and 1 day at could not be induced to undergo coupling with the roomtemperature gave 3e as an off-white powder, after alkynylstannanes. Desilylation and deformylation steps standard extractive work-up and silica-gel chromatog-provided 7-amino cephalosporin derivatives 4a-4d in raphy [IR(nujol) 1780cm" x (/Mactam C=O); XH NMR good yields. by introduction of a substituent to the terminal alkyne position; thus 7e, 7i and 7k displayed potent ( < 1.0 //g/ml)
activity. It is clear from the trends shown in Table 1 that only in the case of a free oxime moiety could a major improvement be observed. Activity against various
Gram-negative bacteria, especially Escherichia coli, was improved when the oxime was alkylated by methyl or ethyl, however in these cases, activity against Grampositve bacteria was unchanged. Since 7b, but not 7a, was reported to have moderate oral absorbability in the earlier papers,5'6) we investigated the urinary recovery of the newcephalosporins prepared in this work in rats (PO, 20mg/kg). However, all compounds showed very low urinary recovery (<10%), this contrasts with cefdinir (-32.5%), 7b JAN. 1997 (~20%),5) and 7a (<5%).6) In summary, we have prepared a series of novel C-3-alkyne-substituted cephalosporins by palladiumcatalysed coupling of mesylate 1 and alkynylstannanes, and have shown that in certain cases, antibacterial activity against both Gram-positive and Gram-negative bacteria can be significantly improved, leading to 7i and 7k as especially active examples.
